Maluba, Salasina M.
HRN: 28-46-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2026
CEFTRIAXONE 1G (VIAL)
01/21/2026
01/27/2026
IV
2g
OD
T/C Sepsis Sec To UTI
Checking Initial Appropriateness
01/25/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/25/2026
02/01/2026
IV
4.5g
Q8h
Sepsis
Checking Initial Appropriateness